Brief: RenovoRx Files New International Patent For Novel Targeted Combination Drug-Delivery Oncology Therapy Platform
13/12/2023 13:39
Dec 13 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX FILES NEW INTERNATIONAL PATENT FOR NOVEL TARGETED
COMBINATION DRUG-DELIVERY ONCOLOGY THERAPY PLATFORM
* RENOVORX INC - COMPANY ANTICIPATES THAT PATENT APPLICATION
WILL
BE PUBLISHED IN MAY OF 2024.
Source text for Eikon: ID:nBwbGL4sPa
Further company coverage: RNXT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RenovoRx
See all newsBrief: RenovoRx Gets FDA Orphan Drug Designation For Oxaliplatin To Treat Pancreatic Cancer
RenovoRx Q1 revenue rises as number of active cancer centers increase
RenovoRx 2025 net loss widens on higher operating expenses
Brief: RenovoRx FY Net Income USD -11.168 Million
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies